Approvals/CIMA-AEMPS/BEMRIST BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)

Approved

STANDARD

BEMRIST BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)

Novartis Europharm Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 1cd432b7ef467000
Drug Cima Aemps Name: BEMRIST BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)
Register Number: 1201441010
Holder Company Name: Novartis Europharm Limited
Marketing Company Name: Laboratorios Gebro Pharma S.A.
Holder Company Detail Path: /organization/novartis-europharm-limited
Authorization Date: 2020-12-16
Dosage Form: POLVO PARA INHALACIÓN (CÁPSULA DURA)
Dose: 125 microgramos/260 microgramos
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Novartis Europharm Limited
Company Detail Path: /organization/novartis-europharm-limited

INDACATEROL ACETATO

0,173 mg

MOMETASONA FUROATO

0,320 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 16, 2020

Approval ID

1cd432b7ef467000

Type

Standard